Literature DB >> 11762252

[Breast cancer: figures and facts].

E Kubista1.   

Abstract

The diagnosis and therapy of breast cancer has been improved and individualized to a great extend during the past two decades. Large randomised trials guide our discussions and new results are integrated continuously into the concept of breast cancer diagnosis and treatment. The new achievements are an increased early detection of breast cancer, a reduction in invasive procedures for diagnosis and operative treatment and an improvement of reconstructive oncoplastic-procedures. Chemo- and hormonal therapy have increased the survival rate and have improved quality of live in advanced disease. The follow-up of patients with breast cancer has to be aimed on regular personal contact, mammography, and gynaecologic follow-up. Other laboratory parameters and imaging techniques have to be reduced and confined for patients with anamnestic or clinical evidence of tumour progression.

Entities:  

Mesh:

Year:  2001        PMID: 11762252

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  8 in total

1.  Diagnostic value of virtual touch tissue imaging quantification for benign and malignant breast lesions with different sizes.

Authors:  Hui Liu; Li-Xia Zhao; Guang Xu; Ming-Hua Yao; Ai-Hong Zhang; Hui-Xiong Xu; Rong Wu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Long-term fatigue state in postoperative patients with breast cancer.

Authors:  Xiao-Fang Tan; Fang Xia
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

3.  The perception of health-related quality of life in colon cancer patients during chemotherapy: differences between men and women.

Authors:  Federica Domati; Gabriele Luppi; Luca Reggiani-Bonetti; Sandra Zironi; Roberta Depenni; Annalisa Fontana; Fabio Gelsomino; Maurizio Ponz de Leon
Journal:  Intern Emerg Med       Date:  2014-12-24       Impact factor: 3.397

4.  BRCA 1 & 2 mutations in Sudanese secondary school girls with known breast cancer in their families.

Authors:  Ahmed M Elnour; Abozer Y Elderdery; Jeremy Mills; Babiker A Mohammed; Daw Elbietabdelaal; Abdelraheem Osman Mohamed; Kamal Eldin H Elhassan; Abdel Hady A; Abdel Wahab; Alan Cooper
Journal:  Int J Health Sci (Qassim)       Date:  2012-01

5.  Assessment of Epstein-Barr virus nucleic acids in gastric but not in breast cancer by next-generation sequencing of pooled Mexican samples.

Authors:  Ezequiel M Fuentes-Pananá; Violeta Larios-Serrato; Alfonso Méndez-Tenorio; Abigail Morales-Sánchez; Carlos F Arias; Javier Torres
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-02-19       Impact factor: 2.743

6.  DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.

Authors:  Lei Zhang; Da-Li Yan; Fan Yang; Dan-Dan Wang; Xiu Chen; Jian-Zhong Wu; Jin-Hai Tang; Wen-Jie Xia
Journal:  Oncotarget       Date:  2017-07-11

7.  Raddeanin A suppresses breast cancer-associated osteolysis through inhibiting osteoclasts and breast cancer cells.

Authors:  Qiang Wang; Jian Mo; Chenchen Zhao; Kangmao Huang; Mingxuan Feng; Wenxin He; Jiying Wang; Shuai Chen; Zi'ang Xie; Jianjun Ma; Shunwu Fan
Journal:  Cell Death Dis       Date:  2018-03-07       Impact factor: 8.469

8.  Outcome of eribulin as a late treatment line for Thai metastatic breast cancer patients.

Authors:  Chagkrit Ditsatham; Imjai Chitapanarux; Areewan Somwangprasert; Kirati Watcharachan; Panchaporn Wongmaneerung; Chaiyut Charoentum; Busyamas Chewaskulyong; Somvilai Chakrabandhu; Wimrak Onchan; Anongnart Teeyasuntranonn; Patumrat Sripan
Journal:  Onco Targets Ther       Date:  2018-07-31       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.